Deucravacitinib is under clinical development by Bristol-Myers Squibb and currently in Phase II for Rosacea. According to GlobalData, Phase II drugs for Rosacea have a 38% phase transition success ...

ACU-D1 is under development for the treatment of severe acne rosacea and HPV associated vulvar and perianal lesions in people with HIV. The drug candidate is a cinnamate compound. The drug candidate ...

Your dermatologist may suggest one of the following laser treatments: Remember that there is only minimal evidence to support ...

If you frequently experience facial redness, irritation and small bumps, you may have rosacea. According to the American Academy of Dermatology, rosacea impacts more than 14 million people in the ...

Rosacea is a common skin malady characterized ... in kids with Crohn's Disease A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn's disease ...

Rosacea is a common and chronic (long-term) skin condition that causes symptoms like facial redness, thickened skin, flushing ...

Rosacea is a condition in which the skin flushes ... FDA “cleared” as a device rather than a drug (Medical Letter on Drugs and Therapeutics, Nov. 11, 2024). Theoretically, this might be ...

Living with skin that’s prone to rosacea isn’t easy. Trying to pin down a trigger for your redness can be exhausting: It could be stress, extreme temperatures, spicy foods, fragrance ...

Considering taking supplements to treat rosacea? Below is a list of common natural remedies used to treat or reduce the symptoms of rosacea. Follow the links to read common uses, side effects ...